Fostering Research

Jussi J. Saukkonen's commentary (The Scientist, April 13, 1992, page 12) suggests that M.D.-Ph.D. programs "should be regarded as an `insurance premium' paid to protect our substantial research investment," and that such programs can make "the student's commitment to long-term training financially feasible." I believe that this approach begs the question of how to encourage bright students to make biomedical research their career, especially given the statement in the same commentary that such

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

I believe that this approach begs the question of how to encourage bright students to make biomedical research their career, especially given the statement in the same commentary that such programs "were never intended to provide the full complement of manpower for medical research."

The "full complement of manpower" can be ensured only by providing hope for at least a somewhat secure financial picture to all prospective scientists.

Most Ph.D. scientists love the intellectual challenge of research and the possibility of contributing to understanding, preventing, and healing diseases. Personal financial gain and security cannot be primary motivators, as most scientists earn considerably less than what they could earn in other fields (including clinical medicine).

Today's insecurity in funding has added a further barrier. People will work for lower pay if they have some assurance that they will be able to do the work they love; however, it is unrealistic to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Bruce Stanley

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide